SQSTM1 and Paget?s Disease of Bone
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Mutations in the Sequestosome 1 gene ( SQSTM1; also known as p62) have recently been identified as the cause of 5q35-linked Paget's disease of bone (PDB). All of the mutations identified to date affect the ubiquitin-associated (UBA) domain of SQSTM1, a region of the protein that binds noncovalently to ubiquitin. In this review we consider the possible functional significance of the SQSTM1-ubiquitin interaction, and consequences of the SQSTM1 UBA domain mutations. Clarification of the in vivo roles of SQSTM1 in bone-cell function will be central to improving our understanding of the molecular pathogenesis of PDB and related conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [404]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 1×
“Consistent with these observations, the UBA domain of SQSTM1 [76, 77] is reported to mediate interaction with both multi-ubiquitin chains [51, 78] and monomeric ubiquitin [79].”
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125 · cited 2×
“upon receptor stimulation [67, 68], is consistent with a model in which the UBA domain of SQSTM1 mediates recruitment of the protein along with aPKCs to signaling complexes via binding to the TRAF6 ubiquitin chain.”
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Recognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716 · cited 1×
“The SQSTM1 protein, via its UBA domain, is able to bind K48-linked multi-ubiquitin chains [51, 78] which, as noted previously, are proteasomal degradation signals when attached to substrate proteins [64].”
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640 · cited 1×
“PEST sequences occur in proteins that are targets of ubiquitindependent proteolysis (see subsequent text) [56], and cell stress associated with arsenite or arsenate is reported to lead to the accumulation of ubiquitylated forms of SQSTM1 in cultured osteoblasts [57].”
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Significantly, RANK is a member of the TNF receptor family [41] that directly interacts with and requires TRAF6 for activation of NFjB signaling [42], and TRAF6-deficient mice lack osteoclasts or show defective osteoclast function [43, 44].”
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595 · cited 1×
“inclusions appear to be neuroprotective [87, 88].”
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & Varshavsky, A. (1989) · Science · doi:10.1126/science.2538923 · Cited by 1,535
T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I
Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A., & Olson, M. F. (2001) · Nature Cell Biology · doi:10.1038/35070009 · Cited by 1,311
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267 · cited 1×
“Significantly, RANK is a member of the TNF receptor family [41] that directly interacts with and requires TRAF6 for activation of NFjB signaling [42], and TRAF6-deficient mice lack osteoclasts or show defective osteoclast function [43, 44].”
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016 · cited 2×
“Interestingly, in addition to the ubiquitylation of TRAF6 that positively regulates NFjB signaling, deubiquitylation of TRAF6 may also in some cases be used as a mechanism to negatively regulate NFjB signaling [70, 71].”
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Ataxin-1 Nuclear Localization and Aggregation
Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y., & Orr, H. T. (1998) · Cell · doi:10.1016/s0092-8674(00)81781-x · Cited by 956 · cited 1×
“inclusions appear to be neuroprotective [87, 88].”
A Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal
Johnson, E. S., Ma, P. C. M., Ota, I. M., & Varshavsky, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17442 · Cited by 821
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 1×
“Significantly, RANK is a member of the TNF receptor family [41] that directly interacts with and requires TRAF6 for activation of NFjB signaling [42], and TRAF6-deficient mice lack osteoclasts or show defective osteoclast function [43, 44].”
p62 Is a Common Component of Cytoplasmic Inclusions in Protein Aggregation Diseases
Zatloukal, K., Stumptner, C., Fuchsbichler, A., Heid, H., Schnoelzer, M., Kenner, L., Kleinert, R., Prinz, M., Aguzzi, A., & Denk, H. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64369-6 · Cited by 624 · cited 2×
“As already discussed, under certain experimental paradigms SQSTM1 is able to sequester ubiquitylated substrates into cellular inclusions, termed sequestosomes [51], which may be equivalent to ‘‘aggresomes’’ and functionally related to SQSTM1-positive neuronal inclusions in human neurodegenerative [52] and liver disord…”
Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., & Matsumoto, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80244-0 · Cited by 610 · cited 1×
“It is also noteworthy that the TAB2 (TAK1-binding protein 2) protein, which links TAK1 to TRAF6 [85], contains a putative ubiquitinbinding CUE domain (coupling of ubiquitin conjugation to ER degradation domains are closely related to UBA domains), but like SQSTM1, the region of TAB2 that binds TRAF6 does not include t…”
Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
Wilkinson, K. D. (2000) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0164 · Cited by 569 · cited 1×
“In addition, family of deubiquitylating enzymes exists that reverse the actions of ubiquitylation [61].”
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 2×
“A recurrent C>T transition at position +1215 on the cDNA sequence of SQSTM1 (NM_003900), which results in a proline to leucine amino acid substitution at codon 392 (P392L), was the first to be identified [30].”
A Ubiquitin Mutant with Specific Defects in DNA Repair and Multiubiquitination
Spence, J., Sadis, S., Haas, A. L., & Finley, D. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1265 · Cited by 550 · cited 1×
“In contrast, conjugation of multi-ubiquitin chains linked via K63 does not signal protein degradation but instead regulating processes including endocytosis [65], DNA repair [66], and Fig.”
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 6×
“These mutations encode six and nine amino acid insertions, respectively, in the signal peptide region of RANK, and both activate NFjB signaling [18].”
InfluentialOsteoprotegerin Deficiency and Juvenile Paget's Disease
Whyte, M. P., Obrecht, S. E., Finnegan, P. M., Jones, J. L., Podgornik, M. N., McAlister, W. H., & Mumm, S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013096 · Cited by 445
The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 2×
“The binding of SQSTM1 to TRAF6 is stimulation dependent [37, 46] and is mediated by a region of SQSTM1 C-terminal of the RIP binding site (the interaction is abrogated by deletion of residues 225–251) allowing SQSTM1 to bind TRAF6 and RIP simultaneously, thereby consistent with SQSTM1’s role as a scaffold protein in N…”
The interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 3×
“The binding of SQSTM1 to TRAF6 is stimulation dependent [37, 46] and is mediated by a region of SQSTM1 C-terminal of the RIP binding site (the interaction is abrogated by deletion of residues 225–251) allowing SQSTM1 to bind TRAF6 and RIP simultaneously, thereby consistent with SQSTM1’s role as a scaffold protein in N…”
Proteins containing the UBA domain are able to bind to multi-ubiquitin chains
Wilkinson, C. R. M., Seeger, M., Hartmann-Petersen, R., Stone, M., Wallace, M., Semple, C., & Gordon, C. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-939 · Cited by 407 · cited 1×
“with multi-ubiquitin chains [72–75] although some UBA domains also apparently interact with monomeric ubiquitin [73], the physiological relevance of which is unclear.”
The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway
Hofmann, K. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)30015-7 · Cited by 404 · cited 1×
“Consistent with these observations, the UBA domain of SQSTM1 [76, 77] is reported to mediate interaction with both multi-ubiquitin chains [51, 78] and monomeric ubiquitin [79].”
Darnay, B. G., Ni, J., Moore, P. A., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7724 · Cited by 399 · cited 1×
“Significantly, RANK is a member of the TNF receptor family [41] that directly interacts with and requires TRAF6 for activation of NFjB signaling [42], and TRAF6-deficient mice lack osteoclasts or show defective osteoclast function [43, 44].”
Ubiquitin Lys63 is involved in ubiquitination of a yeast plasma membrane protein
Galan, J.-M., & Haguenauer-Tsapis, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5847 · Cited by 398 · cited 1×
“In contrast, conjugation of multi-ubiquitin chains linked via K63 does not signal protein degradation but instead regulating processes including endocytosis [65], DNA repair [66], and Fig.”
Interaction Codes within the Family of Mammalian Phox and Bem1p Domain-containing Proteins
Lamark, T., Perander, M., Outzen, H., Kristiansen, K., Øvervatn, A., Michaelsen, E., Bjørkøy, G., & Johansen, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303221200 · Cited by 395 · cited 1×
“as well as NBR1 (next to breast cancer 1) [49, 50], the latter of which shows a domain organization similar to that of SQSTM1.”
Incidence and Natural History of Paget's Disease of Bone in England and Wales
Van Staa, T. P., Selby, P., Leufkens, H. G. M., Lyles, K., Sprafka, J. M., & Prof. Cooper, C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.465 · Cited by 369 · cited 1×
“Although many patients are asymptomatic, 30% experience bone pain, skeletal deformity, deafness, neurological symptoms, and pathological fractures [2].”
Activation of IκB Kinase β by Protein Kinase C Isoforms
Lallena, M.-J., Diaz-Meco, M. T., Bren, G., Payá, C. V., & Moscat, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2180 · Cited by 360
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350 · cited 3×
“In a study of UK-derived familial and sporadic PDB cases, the P392L mutation was found in 13/62 (19%) of families and 9% of sporadic PDB patients [31].”
Self-citationUBA domains of DNA damage-inducible proteins interact with ubiquitin.
Bertolaet, B. L., Clarke, D. J., Wolff, M., Watson, M. H., Henze, M., Divita, G., & Reed, S. I. (2001) · Nature Structural Biology · doi:10.1038/87575 · Cited by 336
Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316 · cited 4×
“In addition, defective NFjB signaling can clearly lead to PDB-like phenotypes [18, 20, 24, 25], and preliminary evidence suggests (at least the most common P392L) SQSTM1 PDB mutation(s) may indeed lead to activation of NFjB signaling [46].”
InfluentialPathophysiology and Treatment of Paget's Disease of Bone
Kanis, J. А. (1991) · Medical Entomology and Zoology · Cited by 308
Vadlamudi, R. K., Joung, I., Strominger, J. L., & Shin, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20235 · Cited by 298 · cited 1×
“Consistent with these observations, the UBA domain of SQSTM1 [76, 77] is reported to mediate interaction with both multi-ubiquitin chains [51, 78] and monomeric ubiquitin [79].”
Rad23 Promotes the Targeting of Proteolytic Substrates to the Proteasome
Chen, L., & Madura, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4902-4913.2002 · Cited by 290 · cited 1×
“Proposed mechanisms of regulation of ubiquitin-dependent proteolysis by UBA domain proteins include delivery of multi-ubiquitylated targets to the 26S proteasome [80], sequestration of multi-ubiquitylated targets precluding proteasomal”
Mizukami, J., Takaesu, G., Akatsuka, H., Sakurai, H., Ninomiya-Tsuji, J., Matsumoto, K., & Sakurai, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.992-1000.2002 · Cited by 283
Raasi, S., & Pickart, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212841200 · Cited by 250
Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome
Funakoshi, M., Sasaki, T., Nishimoto, T., & Kobayashi, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012585199 · Cited by 248
Frequency and characteristics of familial aggregation of paget's disease of bone
Morales-Piga, A. A., Rey-Rey, J. S., Corres-González, J., Garc ÍA-Sagredo, J. M., & LÓPez-Abente, G. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100421 · Cited by 236
Wilson, M. I., Gill, D. J., Perisic, O., Quinn, M. T., & Williams, R. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00246-6 · Cited by 231 · cited 1×
“The N-terminus ( 80 residues) of the SQSTM1 protein contains a PB1 (Phox and Bem1) domain through which the protein is able to bind corresponding PB1 domains in aPKCs [47, 48].”
Bedford, F. K., Kittler, J. T., Muller, E., Thomas, P., Uren, J. M., Merlo, D., Wisden, W., Triller, A., Smart, T. G., & Moss, S. J. (2001) · Nature Neuroscience · doi:10.1038/nn0901-908 · Cited by 231 · cited 1×
“These include interactions between the UBA domains of hHR23A and the human immunodeficiency virus Vpr protein [90] and 3methyladenine-DNA glycosylase [91]; the PLIC-1 UBA domain and the a1 subunit of the GABAA receptor [92]; the hPLIC-1 UBA domain and presenilins 1 and 2 [93]; and the hPLIC-2 UBA domain and the 26S pr…”
Mechanism of Ubiquitin Recognition by the CUE Domain of Vps9p
Prag, G., Misra, S., Jones, E. A., Ghirlando, R., Davies, B. A., Horazdovsky, B. F., & Hurley, J. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00364-7 · Cited by 230 · cited 1×
“[98]) such that the P392L and G411S mutations may in fact affect ubiquitin-binding.”
Cundy, T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2119 · Cited by 228 · cited 2×
“In addition, defective NFjB signaling can clearly lead to PDB-like phenotypes [18, 20, 24, 25], and preliminary evidence suggests (at least the most common P392L) SQSTM1 PDB mutation(s) may indeed lead to activation of NFjB signaling [46].”
Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates
Donaldson, K. M., Li, W., Ching, K. A., Batalov, S., Tsai, C.-C., & Joazeiro, C. A. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530212100 · Cited by 225 · cited 1×
“model, although whether the presence of inclusions in this case correlated with cell survival was not addressed [89].”
Structure and functional properties of the ubiquitin binding protein p62
Geetha, T., & Wooten, M. W. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02286-x · Cited by 223 · cited 1×
“The protein encoded by the human SQSTM1 gene has been implicated in diverse cellular functions [35] including modulation of potassium channel function, control of transcriptional activation, protein recruitment to endosomes, and, probably most relevant to PDB, control of NFjB signaling.”
Chen, L., Shinde, U., Ortolan, T. G., & Madura, K. (2001) · EMBO reports · doi:10.1093/embo-reports/kve203 · Cited by 218 · cited 2×
“For example, binding of SQSTM1 to nonubiquitylated TRAF6 could allow SQSTM1 to subsequently use its UBA domain to regulate K63linked ubiquitin chain assembly or disassembly [74, 82] on TRAF6.”
Huvos, A. G. (1986) · Cancer · doi:10.1002/1097-0142(19860401)57:7<1442::aid-cncr2820570734>3.0.co;2-3 · Cited by 218 · cited 1×
“The most serious complication of PDB is osteosarcoma; although this is rare, affecting<1% of patients, the majority of osteosarcomas that occur in adulthood do so in patients with PDB [3].”
Kuusisto, E., Salminen, A., & Alafuzoff, I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00394.x · Cited by 217 · cited 3×
“In Alzheimer’s disease, SQSTM1 is an early component of neurofibrillary tangles, suggesting that the protein may play a role in the maturation and recruitment of ubiquitylated proteins to these lesions [52].”
Interaction of protein kinase C ζ with ZIP, a novel protein kinase C-binding protein
Puls, A., Schmidt, S., Grawe, F., & Stabel, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6191 · Cited by 213 · cited 1×
“The N-terminus ( 80 residues) of the SQSTM1 protein contains a PB1 (Phox and Bem1) domain through which the protein is able to bind corresponding PB1 domains in aPKCs [47, 48].”
ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins
Ponting, C. P., Blake, D. J., Davies, K. E., Kendrick-Jones, J., & Winder, S. J. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(06)80020-4 · Cited by 204 · cited 1×
“The ZZ domain of SQSTM1 is a novel zinc finger motif [55] between residues 128 and 163 of the protein, which is critical for the interaction of SQSTM1 with RIP [39], as it links aPKCs to TNFa signaling complexes.”
Mah, A. L., Perry, G., Smith, M. A., & Monteiro, M. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.4.847 · Cited by 203 · cited 1×
“These include interactions between the UBA domains of hHR23A and the human immunodeficiency virus Vpr protein [90] and 3methyladenine-DNA glycosylase [91]; the PLIC-1 UBA domain and the a1 subunit of the GABAA receptor [92]; the hPLIC-1 UBA domain and presenilins 1 and 2 [93]; and the hPLIC-2 UBA domain and the 26S pr…”
Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain.
Joung, I., Strominger, J. L., & Shin, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5991 · Cited by 194 · cited 1×
“nus of the SQSTM1 protein also binds the Src homology 2 (SH2) domain of p56 [54], although in this case the interaction is not based on PB1–PB1 domain interactions.”
Wooten, M. W., Seibenhener, M. L., Mamidipudi, V., Diaz-Meco, M. T., Barker, P. A., & Moscat, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000869200 · Cited by 180 · cited 1×
“Through stimulation-dependent interaction with TRAF6, SQSTM1 is able to recruit atypical protein kinase C (aPKC) proteins, which regulate NFjB activation via phosphorylation of IjB kinase ß (IKKß) [36], to interleukin-1 (IL-1) and nerve growth factor (NGF)–signaling complexes [37, 38].”
The selective vulnerability of nerve cells in Huntington's disease
Sieradzan, K. A., & Mann, D. M. A. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00299.x · Cited by 180
Whyte, M. P., & Hughes, A. E. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.26 · Cited by 180 · cited 3×
“In addition, defective NFjB signaling can clearly lead to PDB-like phenotypes [18, 20, 24, 25], and preliminary evidence suggests (at least the most common P392L) SQSTM1 PDB mutation(s) may indeed lead to activation of NFjB signaling [46].”
Transferring substrates to the 26S proteasome
Hartmann-Petersen, R., Seeger, M., & Gordon, C. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00002-6 · Cited by 170 · cited 1×
“UBA domains are short ( 50 residue) sequences that are present in enzymes of the ubiquitin conjugation and deconjugation pathway [58], as well as in proteins that are regulators of ubiquitin-dependent proteolysis or other ubiquitin-mediated processes (reviewed in [59]).”
Hocking, L. J., Lucas, G. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Donath, J., Walsh, J. P., Finlayson, C., Cavey, J. R., Ciani, B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0403015 · Cited by 156 · cited 6×
“3%) individuals affected with sporadic PDB [33].”
InfluentialSelf-citationGenetic Linkage of Paget Disease of the Bone to Chromosome 18q
Cody, J. D., Singer, F. R., Roodman, G. D., Otterund, B., Lewis, T. B., Leppert, M., & Leach, R. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301601 · Cited by 151 · cited 4×
“Positional cloning studies showed that the gene for receptor activator of NFjB (RANK) lay within the PDB2 critical region, and mutation screening identified a heterozygous 18-bp tandem in-frame repeat within exon one of RANK in individuals from three families affected with FEO [18] and a 27-bp repeat in individuals fr…”
InfluentialHelfrich, M. H., Hobson, R. P., Grabowski, P. S., Zurbriggen, A., Cosby, S. L., Dickson, G. R., Fraser, W. D., Ooi, C. G., Selby, P. L., Crisp, A. J., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2315 · Cited by 147 · cited 1×
“There are also suggestions that PDB might be caused by a slow virus infection of bone cells with one of the paramyxoviruses [11], although evidence in support of this hypothesis is conflicting and the role of viruses in the pathogenesis of PDB currently remains uncertain [12].”
P62 and the sequestosome, a novel mechanism for protein metabolism
Shin, J. (1998) · Archives of Pharmacal Research · doi:10.1007/bf02976748 · Cited by 146 · cited 5×
“Through its PB1 domain, SQSTM1 is able to assemble into homotypic complexes in so called ‘‘front-to-back’’ arrays [48–50], which may be related to the ability of the protein to form ‘‘sequestosomes’’ (hence, the name sequestosome 1 or SQSTM1) [51].”
InfluentialHaslam, S. I., Van Hul, W., Morales-Piga, A., Balemans, W., San-Millan, J. L., Nakatsuka, K., Willems, P., Haites, N. E., & Ralston, S. H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.911 · Cited by 139 · cited 4×
“Positional cloning studies showed that the gene for receptor activator of NFjB (RANK) lay within the PDB2 critical region, and mutation screening identified a heterozygous 18-bp tandem in-frame repeat within exon one of RANK in individuals from three families affected with FEO [18] and a 27-bp repeat in individuals fr…”
InfluentialPaget Disease of Bone: Mapping of Two Loci at 5q35-qter and 5q31
Laurin, N., Brown, J. P., Lemainque, A., Duchesne, A., Huot, D., Lacourcière, Y., Drapeau, G., Verreault, J., Raymond, V., & Morissette, J. (2001) · The American Journal of Human Genetics · doi:10.1086/322975 · Cited by 139 · cited 2×
“ease on chromosomes 5q35 (PDB3) [27, 28] 5q31 (PDB4) [28], 2q36 (PDB5) [27], 10p13 (PDB6), and 18q23 (PDB7) [29].”
Mallory body—A disease-associated type of sequestosome
Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., & Denk, H. (2002) · Hepatology · doi:10.1053/jhep.2002.32674 · Cited by 135 · cited 1×
“SQSTM1 is reported to bind multi-ubiquitylated proteins that accumulate when the proteasome degradative function is impaired [51, 83], and in cultured cells treated with proteasome inhibitors SQSTM1 is able to sequester ubiquitylated substrates into ‘‘sequestosomes’’ [51].”
Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders
Layfield, R., Cavey, J. R., & Lowe, J. S. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00025-4 · Cited by 133 · cited 1×
“Certainly defective ubiquitin-dependent proteolysis can directly cause or contribute to major human diseases [96], and cellular inclusion formation is relevant to cell death/survival in diverse disease states [97].”
Self-citationA family study of Paget's disease of bone.
Sofaer, J. A., Holloway, S. M., & Emery, A. E. (1983) · Journal of Epidemiology and Community Health · doi:10.1136/jech.37.3.226 · Cited by 133
Siris, E. S. (1994) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(94)90037-x · Cited by 128
Ciani, B., Layfield, R., Cavey, J. R., Sheppard, P. W., & Searle, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307416200 · Cited by 128
Self-citationEvaluation of the role of RANK and OPG genes in Paget’s disease of bone
Wuyts, W. A., Wesenbeeck, L. V., Morales-Piga, A. A., Ralston, S. H., Hocking, L. J., Vanhoenacker, F. M. H. M., Westhovens, R., Verbruggen, L., Anderson, D. M., Hughes, A., et al. (2001) · Bone · doi:10.1016/s8756-3282(00)00411-7 · Cited by 121 · cited 1×
“Although this illustrates the importance of mutations in the RANK signaling pathway as a cause of PDB-like phenotypes, mutations in RANKL and OPG have been excluded as a common cause of late-onset sporadic and familial PDB [26].”
Self-citation3-Methyladenine-DNA Glycosylase (MPG Protein) Interacts with Human RAD23 Proteins
Miao, F., Bouziane, M., Dammann, R., Masutani, C., Hanaoka, F., Pfeifer, G., & O'Connor, T. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001064200 · Cited by 120 · cited 1×
“These include interactions between the UBA domains of hHR23A and the human immunodeficiency virus Vpr protein [90] and 3methyladenine-DNA glycosylase [91]; the PLIC-1 UBA domain and the a1 subunit of the GABAA receptor [92]; the hPLIC-1 UBA domain and presenilins 1 and 2 [93]; and the hPLIC-2 UBA domain and the 26S pr…”
Long-term trends in the incidence of Paget’s disease of bone
Tiegs, R. D., Lohse, C. M., Wollan, P. C., & Melton, L. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00333-1 · Cited by 120 · cited 2×
“interest that epidemiological studies over a 40-year period have shown no major changes in PDB incidence in Rochester, Minnesota [14].”
Nakatsuka, K., Nishizawa, Y., & Ralston, S. H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1381 · Cited by 119 · cited 1×
“Positional cloning studies showed that the gene for receptor activator of NFjB (RANK) lay within the PDB2 critical region, and mutation screening identified a heterozygous 18-bp tandem in-frame repeat within exon one of RANK in individuals from three families affected with FEO [18] and a 27-bp repeat in individuals fr…”
Bertolaet, B. L., Clarke, D. J., Wolff, M., Watson, M. H., Henze, M., Divita, G., & Reed, S. I. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5105 · Cited by 118
Genetic linkage of familial expansile osteolysis to chromosome 18q
Hughes, A. E., Shearman, A. M., Weber, J. L., Barr, R. J., Wallace, R. G. H., Osterberg, P. H., Nevin, N. C., & A.B.Mollan, R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.2.359 · Cited by 117 · cited 1×
“to chromosome 18q21–22 [16], and subsequently some cases of familial PDB were mapped to the same region (PDB2) [9, 17].”
Hocking, L. J., Herbert, C. A., Nicholls, R. K., Williams, F., Bennett, S. T., Cundy, T., Nicholson, G. C., Wuyts, W. A., Hul, W. V., & Ralston, S. H. (2001) · The American Journal of Human Genetics · doi:10.1086/323798 · Cited by 116 · cited 2×
“ease on chromosomes 5q35 (PDB3) [27, 28] 5q31 (PDB4) [28], 2q36 (PDB5) [27], 10p13 (PDB6), and 18q23 (PDB7) [29].”
Self-citationThree novel mutations in SQSTM1 identified in familial Paget’s disease of bone.
Johnson-Pais, T. L., Wisdom, J. H., Weldon, K. S., Cody, J. D., Hansen, M. F., Singer, F. R., & Leach, R. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1748 · Cited by 110 · cited 1×
“grees, as was a novel C>T transition at position +1200 resulting in a proline to leucine substitution at codon 387 (P387L; [34]), and the P392L, M404V and G425R mutations were identified in an Italian series of patients affected with PDB [99].”
The Ubiquitin-associated Domain of hPLIC-2 Interacts with the Proteasome
Kleijnen, M. F., Alarcón, R. M., & Howley, P. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0766 · Cited by 107 · cited 1×
“These include interactions between the UBA domains of hHR23A and the human immunodeficiency virus Vpr protein [90] and 3methyladenine-DNA glycosylase [91]; the PLIC-1 UBA domain and the a1 subunit of the GABAA receptor [92]; the hPLIC-1 UBA domain and presenilins 1 and 2 [93]; and the hPLIC-2 UBA domain and the 26S pr…”
Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts
Aono, J., Yanagawa, T., Itoh, K., Li, B., Yoshida, H., Kumagai, Y., Yamamoto, M. P., & Ishii, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00728-9 · Cited by 103 · cited 1×
“PEST sequences occur in proteins that are targets of ubiquitindependent proteolysis (see subsequent text) [56], and cell stress associated with arsenite or arsenate is reported to lead to the accumulation of ubiquitylated forms of SQSTM1 in cultured osteoblasts [57].”
Withers-Ward, E. S., Jowett, J. B. M., Stewart, S. A., Xie, Y. M., Garfinkel, A., Shibagaki, Y., Chow, S. A., Shah, N. P., Hanaoka, F., Sawitz, D. G., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9732-9742.1997 · Cited by 98
Molecular Recognition in Dimerization between PB1 Domains
Noda, Y., Kohjima, M., Izaki, T., Ota, K., Yoshinaga, S., Inagaki, F., Ito, T., & Sumimoto, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306330200 · Cited by 93 · cited 1×
“as well as NBR1 (next to breast cancer 1) [49, 50], the latter of which shows a domain organization similar to that of SQSTM1.”
Falchetti, A., Di Stefano, M., Marini, F., Del Monte, F., Mavilia, C., Strigoli, D., De Feo, M. L., Isaia, G., Masi, L., Amedei, A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040203 · Cited by 87
Familial Paget’s disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q
Hocking, L. J., Slee, F., Haslam, S. I., Cundy, T., Nicholson, G. C., Hul, W. V., & Ralston, S. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00278-7 · Cited by 87 · cited 1×
“Fine mapping of the 18q21–22 locus excluded linkage across the entire PDB2 region in lateonset familial PDB [8, 21, 22], and mutation screening of RANK in U.”
Self-citationLinkage of Paget Disease of Bone to a Novel Region on Human Chromosome 18q23
Good, D. M., Busfield, F., Fletcher, B. H., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338658 · Cited by 86 · cited 2×
“ease on chromosomes 5q35 (PDB3) [27, 28] 5q31 (PDB4) [28], 2q36 (PDB5) [27], 10p13 (PDB6), and 18q23 (PDB7) [29].”
Sparks, A. B., Peterson, S. N., Bell, C., Loftus, B., Hocking, L. J., Cahill, D. P., Frassica, F. J., Streeten, E. A., Levine, M. A., Fraser, C. M., et al. (2001) · Calcified Tissue International · doi:10.1007/s002230001211 · Cited by 83 · cited 1×
“pagetic families and in a series of individuals with sporadic PDB failed to identify any diseasecausing mutations [23].”
Self-citationThe ubiquitin protein catabolic disorders
Layfield, R., Alban, A., Mayer, R. J., & Lowe, J. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00335.x · Cited by 80 · cited 1×
“Certainly defective ubiquitin-dependent proteolysis can directly cause or contribute to major human diseases [96], and cellular inclusion formation is relevant to cell death/survival in diverse disease states [97].”
Self-citationIshida, Y., & Heersche, J. N. M. (1997) · Bone · doi:10.1016/s8756-3282(96)00315-8 · Cited by 77
Harvey, L., Gray, T., Beneton, M. N. C., Douglas, D. L., Kanis, J. А., & Russell, R. G. G. (1982) · Journal of Clinical Pathology · doi:10.1136/jcp.35.7.771 · Cited by 67
Mouse models of abnormal skeletal development and homeostasis
McLean, W., & Olsen, B. R. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02458-1 · Cited by 64 · cited 1×
“SQSTM1 and RANK are, therefore, likely to be common components of a TRAF6-dependent signaling pathway that regulates bone cell function via NFjB activity [45, 46] (Fig.”
The epidem gy of pagers disease
BARKER, D. J. P. (1981) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(81)90037-0 · Cited by 57
Ubiquitin binding proteins protect ubiquitin conjugates from disassembly
Hartmann-Petersen, R., Hendil, K. B., & Gordon, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03874-7 · Cited by 56 · cited 2×
“For example, binding of SQSTM1 to nonubiquitylated TRAF6 could allow SQSTM1 to subsequently use its UBA domain to regulate K63linked ubiquitin chain assembly or disassembly [74, 82] on TRAF6.”
Paget's Disease in an Archeological Population
Rogers, J., Jeffrey, D., & Watt, I. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1127 · Cited by 47 · cited 1×
“In addition, archaeological studies of skeletal remains in the United Kingdom have shown that the prevalence of PDB between the fifteenth and nineteenth centuries is quite similar to the prevalence today, excluding major changes in disease incidence over the past 500 years [15].”
Voorhess, M. L., Brecher, M. L., Glicksman, A. S., Jones, B., Harris, M., Krischer, J. P., Boyett, J. M., Forman, E. N., & Freeman, A. I. (1986) · Cancer · doi:10.1002/1097-0142(19860401)57:7<1324::aid-cncr2820570712>3.0.co;2-a · Cited by 45
Paget's disease (Osteitis deformans) and heredity.
Mf, M. (1949) · PubMed Central · Cited by 36
Good, D., Busfield, F., Duffy, D., Lovelock, P. K., Kesting, J. B., Cameron, D. P., & Shaw, J. T. E. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.33 · Cited by 36 · cited 1×
“Fine mapping of the 18q21–22 locus excluded linkage across the entire PDB2 region in lateonset familial PDB [8, 21, 22], and mutation screening of RANK in U.”
Pathophysiology and treatment of Paget's disease of bone
Crisp, A. J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.2.92-a · Cited by 34
Seeking the elusive etiology of paget disease: A progress report
Siris, E. S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111102 · Cited by 29 · cited 1×
“There are also suggestions that PDB might be caused by a slow virus infection of bone cells with one of the paramyxoviruses [11], although evidence in support of this hypothesis is conflicting and the role of viruses in the pathogenesis of PDB currently remains uncertain [12].”
Heterogeneity in Paget disease of the bone
Nance, M. A., Nuttall, F. Q., Econs, M. J., Lyles, K. W., Viles, K. D., Vance, J. M., Pericak-Vance, M. A., & Speer, M. C. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000619)92:5<303::aid-ajmg2>3.0.co;2-e · Cited by 24 · cited 1×
“Fine mapping of the 18q21–22 locus excluded linkage across the entire PDB2 region in lateonset familial PDB [8, 21, 22], and mutation screening of RANK in U.”
Research works printed but not linked: 6
- AG Huvos, 1986, A clinicopathologic analysis of 117 patients older than 60 years. Cancer, 57, 1442
- MFA Montagu, 1949, Am J Hum Genet, 1, 94
- K Shafheutle, 1997, Bone, 20, O017
- DA Good, 2002, Single base-pair deletion of gene encoding Sequestosome 1 (SQSTM1/p62) in Paget?s disease of bone. [abstract 04:13]. ANZBMS 12th Annual Scientific Meeting
- K Hofmann, 1996, Trends Biochem Sci, 21, 172, 10.1016/S0968-0004(96)30015-7 · doi:10.1016/s0968-0004(96)30015-7 · Paper page
- K Hofmann, 1996, Trends Biochem Sci, 21, 172, 10.1016/S0968-0004(96)30015-7 · doi:10.1016/s0968-0004(96)30015-7 · Paper page
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Sun, S.-C. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.43 · Cited by 400
“Deregulated osteoclast activity is the major cause of bone erosion in osteolytic diseases, such as osteoporosis, rheumatoid arthritis, and Paget’s disease of bone.(74,75) The development of osteoclasts is driven by signal transduction mediated by a TNFR family member, RANK.”
BackgroundPathogenesis and management of Paget's disease of bone
Ralston, S. H., Langston, A. L., & Reid, I. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61035-1 · Cited by 260
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
“Such genetic alterations of p62 are etiologically associated with development of Paget disease of bone (PDB), a severe bone disorder characterized by formation of giant OCs, excessive bone resorption, and irregular bone formation (15, 19, 20).”
BackgroundKimonis, V. E., Mehta, S. G., Fulchiero, E. C., Thomasova, D., Pasquali, M., Boycott, K., Neilan, E. G., Kartashov, A., Forman, M. S., Tucker, S., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31862 · Cited by 175
Metadata
- Authors
- Layfield, R., & Hocking, L. J.
- Affiliations
- University of Nottingham (GB)
- University of Aberdeen (GB)
- Corresponding author
- Layfield, R.
- Venue
- Calcified Tissue International
- Published
- 2004-09-16
- Volume
- 75
- Issue
- 5
- Pages
- 347-357
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2045763473
- Cited by
- 76
- References
- 100
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 5 · 2013: 2 · 2012: 6
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p62, Paget's disease of bone, UBA domain, ubiquitin binding, bone cell function, molecular pathogenesis, genetic mutations
- MeSH terms
- DNA Mutational Analysis, Humans, Models, Biological, Models, Molecular, Mutation, Osteitis Deformans, Proteins, Protein Structure, Tertiary, Ubiquitin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.